EDGAR Filing Documents for 0001102624-14-001486

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001102624-14-001486

Filing Date

2014-09-11

Accepted

2014-09-10 18:52:04

Documents

Period of Report

2014-05-31

Document Format Files

Seq	Description	Document	Type	Size
1	MEDICURE INC. 20-F	medicure20f.htm	20-F	2513610
2	EXHIBIT 1.7	exh1_7.htm	EX-1.7	4036
3	EXHIBIT 1.8	exh1_8.htm	EX-1.8	261018
4	EXHIBIT 4.28	exh4_28.htm	EX-4.28	76957
5	EXHIBIT 12.1	exh12_1.htm	EX-12.1	13030
6	EXHIBIT 12.2	exh12_2.htm	EX-12.2	13116
7	EXHIBIT 13.1	exh13_1.htm	EX-13.1	8513
8	EXHIBIT 23.1	exh23_1.htm	EX-23.1	6912
9	IMAGE	ernstyoungsig.jpg	GRAPHIC	5760
10	IMAGE	exh17p1.jpg	GRAPHIC	70987
11	IMAGE	exh17p2.jpg	GRAPHIC	79864
12	IMAGE	exh17p3.jpg	GRAPHIC	65618
	Complete submission text file	0001102624-14-001486.txt		3204911

Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6

Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412

MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 20-F | Act: 34 | File No.: 001-31995 | Film No.: 141096739
SIC: 2834 Pharmaceutical Preparations